Orchid Pharma Gets DCGI Approval for Enmetazobactam
Orchid Pharma has secured Drugs Controller General of India (DCGI) approval for the manufacturing and marketing of its invented New Chemical Entity Active Pharmaceutical Ingredient (API), Enmetazobactam.
Drugs Controller General Of India | 10/06/2024 | By Aishwarya | 114
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy